(Q39488901)

English

Helper strategy in tumor immunology: expansion of helper lymphocytes and utilization of helper lymphokines for experimental and clinical immunotherapy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 September 2017

1 reference

Europe PubMed Central

Helper strategy in tumor immunology: expansion of helper lymphocytes and utilization of helper lymphokines for experimental and clinical immunotherapy (English)

1 reference

Europe PubMed Central

12 September 2017

0 references

1 reference

based on heuristic

inferred from title

0 references

Mirella Giovarelli

object named as

M Giovarelli

7

0 references

author name string

G Forni

1

1 reference

Europe PubMed Central

12 September 2017

H Fujiwara

2

1 reference

Europe PubMed Central

12 September 2017

F Martino

3

1 reference

Europe PubMed Central

12 September 2017

T Hamaoka

4

1 reference

Europe PubMed Central

12 September 2017

C Jemma

5

1 reference

Europe PubMed Central

12 September 2017

P Caretto

6

1 reference

Europe PubMed Central

12 September 2017

publication date

1 December 1988

1 reference

Europe PubMed Central

12 September 2017

Cancer and Metastasis Reviews

1 reference

Europe PubMed Central

12 September 2017

7

1 reference

Europe PubMed Central

12 September 2017

289-309

1 reference

Europe PubMed Central

12 September 2017

4

1 reference

Europe PubMed Central

12 September 2017

https://scigraph.springernature.com/pub.10.1007/bf00051371

0 references

Induction of tumor cell rejection in the low responsive YAC-lymphoma strain A host combination by immunization with somatic cell hybrids

1 reference

https://api.crossref.org/works/10.1007%2FBF00051371

21 January 2018

Mechanisms for recognition of tumor antigens and mediation of anti-tumor effect by noncytolytic Lyt-2+ T cell subset

1 reference

https://api.crossref.org/works/10.1007%2FBF00051371

21 January 2018

Requirements of adherent cells for activating Lyt-1+2- T cells as well as for functioning as antitumor effectors activated by factor(s) from Lyt-1+2- T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro reeducated T helper cells from sarcoma-bearing mice inhibit sarcoma growth in vivo.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ability of CBA mice to produce anti-idiotypic sera to 5563 myeloma protein.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cross-reactivity between haptenic muramyl di- or tripeptide derivatives and Mycobacterium bovis BCG: potential application for enhancing tumor immunity.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The augmentation of tumor-specific immunity using haptenic muramyl dipeptide (MDP) derivatives. II. Establishment of tumor-specific immunotherapy models utilizing MDP hapten-reactive helper T cell activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Both L3T4+ and Lyt-2+ helper T cells initiate cytotoxic T lymphocyte responses against allogenic major histocompatibility antigens but not against trinitrophenyl-modified self

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of recurrent squamous cell carcinoma of the head and neck with low doses of interleukin-2 injected perilymphatically

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thy and Ly markers on lymphocytes initiating tumor rejection.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immune recognition of tumor cellsin vivo. I. Role of H-2 gene products in T lymphocyte activation against minor histocompatibility antigens displayed by adenocarcinoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phenotypes associated with tumor rejection mediated by cyclophosphamide and syngeneic tumor-sensitized T lymphocytes: potential mechanisms of action

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional subclasses of T lymphocytes bearing different Ly antigens. II. Cooperation between subclasses of Ly+ cells in the generation of killer activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulatory functions of hapten-reactive helper and suppressor T lymphocytes. III. Amplification of a generation of tumor-specific killer T-lymphocyte activities by suppressor T-cell-depleted hapten-reactive T lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumour inhibition by interleukin-2 at the tumour/host interface

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adoptive immunotherapy of established syngeneic solid tumors: role of T lymphoid subpopulations

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor-specific immunotherapy by active immunization with haptenic muramyl dipeptide derivative-coupled tumor cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alloantigen-activated lymphocytes from mice bearing a spontaneous "nonimmunogenic" adenocarcinoma inhibit its growth in vivo by recruiting host immunoreactivity.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Augmented induction of tumor-specific resistance by priming with Mycobacterium tuberculosis (TBC) and subsequent immunization with PPD-coupled syngeneic tumor cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of transplantation immunity by dansylated tumor cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular biology of interleukin 4 and interleukin 5 genes and biology of their products that stimulate B cells, T cells and hemopoietic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cellular mechanisms of tumor rejection in vivo and enhanced induction of anti tumor protective immunity applicable to tumor-specific immunotherapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Studies on the recovery from tolerance to tumor antigens. I. Bone marrow cells from tolerant hosts are not rendered tolerant, but provide potential to reconstitute tumor-specific effector T cell clones

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The augmentation of tumor-specific immunity using haptenic muramyl dipeptide (MDP) derivatives. III. Eradication of disseminated murine chronic leukemia cells by utilizing MDP hapten-reactive helper T-cell activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immune mechanisms in homotransplantation. II. Quantitative assay of the immunologic activity of lymphoid cells stimulated by tumor homografts

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon production in mixed cultures of murine leukocytes and syngeneic L1210 leukemia cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Generation of lytic and proliferative lymphoid clones to syngeneic tumor: in vitro and in vivo studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The augmentation of tumor-specific immunity by virus help. I. Demonstration of vaccinia virus-reactive helper T cell activity involved in enhanced induction of cytotoxic T lymphocyte and antibody responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of passively transferred immunity against an established tumor depends on generation of cytolytic T cells in recipient. Inhibition by suppressor T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphokine-activated tumor inhibition in vivo. I. The local administration of interleukin 2 triggers nonreactive lymphocytes from tumor-bearing mice to inhibit tumor growth.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specific adoptive immunotherapy with tumor-specific cytotoxic T-lymphocyte clone for murine malignant gliomas.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin 2 activated tumor inhibition in vivo depends on the systemic involvement of host immunoreactivity

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of immune responsiveness in a genetically low-responsive tumor-host combination by chemical modification of the immunogen

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunologic approach to cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The augmentation of in vitro and in vivo tumor-specific T cell-mediated immunity by amplifier T lymphocytes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T cells cooperating in the induction of delayed-type hypersensitivity act via the linked recognition of antigenic determinants

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular analysis of the interleukin-2 system

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of tumor metastasis after surgical removal of primary tumor by using in vitro activated macrophages

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of T cell sets in the rejection of a methylcholanthrene-induced sarcoma (S1509a) in syngeneic mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of the Murine Antigenic Determinant, Designated L3T4a, Recognized by Monoclonal Antibody GK 1.5: Expression of L3T4a by Functional T Cell Clones Appears to Correlate Primarily with Class II MHC Antigen-Reactivity

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor immunotherapy by local injection of interleukin 2 and non-reactive lymphocytes. Experimental and clinical results

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elimination of syngeneic sarcomas in rats by a subset of T lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiple functions of natural killer cells, including immunoregulation as well as resistance to tumor growth.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence implicating L3T4 in class II MHC antigen reactivity; monoclonal antibody GK1.5 (anti-L3T4a) blocks class II MHC antigen-specific proliferation, release of lymphokines, and binding by cloned murine helper T lymphocyte lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro generation of antigen-specific helper T cells that collaborate with cytotoxic T-cell precursors

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protection against syngeneic lymphoma by a long-lived cytotoxic T-cell clone

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The regulatory influence of activated T cells on B cell responses to antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Production of multiple cytokines by clones of human large granular lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The specific direct interaction of helper T cells and antigen-presenting B cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T-T cell interactions during in vitro cytotoxic T lymphocyte responses. III. Antigen-specific T helper cells release nonspecific mediator(s) able to help induction of H-2-restricted cytotoxic T lymphocyte responses across cell-impermeable membranes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cell-mediated cytotoxicity, allograft rejection, and tumor immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T-T cell interaction in the in vitro induction of delayed-type hypersensitivity (DTH) responses: demonstration of vaccinia virus-reactive helper T cell activity involved in enhanced induction of DTH responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Coclustering of CD4 (L3T4) molecule with the T-cell receptor is induced by specific direct interaction of helper T cells and antigen-presenting cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Significance of Lyt phenotypes: Lyt2 antibodies block activities of T cells that recognize class 1 major histocompatibility complex antigens regardless of their function

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cell reactivity towards syngeneic neoplastic cells in mice hypersensitized to dinitrophenol

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Cell-Mediated Immune Response: Interactions of Initiator and Recruited T Lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A preliminary trial of vaccinia oncolysates in the treatment of recurrent melanoma with serologic responses to the treatment.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of Ir gene control of cytotoxic response to hapten-modified self: helper T cells specific for a sulfhydryl hapten can substitute for an anti-TNP-H-2b self helper cell defect

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic tumor rejection induced by the intravenous injection of Lyt-2+ cytolytic T lymphocyte clones

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of interferon-gamma may suppress allograft reactivity by T lymphocytes in vitro and in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunity to methylcholanthrene-induced sarcomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antigenic properties of methylcholanthrene-induced tumors in mice of the strain of origin

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Viral oncolysis: increased immunogenicity of host cell antigen associated with influenza virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhanced immunogenicity of chemically-coated syngeneic tumor cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Studies on macrophage-activating factor (MAF) in antitumor immune responses. II. Molecular characterization of MAF produced by the tumor-immune Lyt-1+2- T cell subset

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of helper T cells on the primary in vitro production of delayed-type hypersensitivity to influenza virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A short synthetic peptide fragment of human interleukin 1 with immunostimulatory but not inflammatory activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T cell nature of some lymphokine-activated killer (LAK) cells. Frequency analysis of LAK precursors within human T cell populations and clonal analysis of LAK effector cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergy among lymphoid cells mediating the graft-versus-host response. I. Synergy in graft-versus-host reactions produced by cells from NZB-Bl mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunosuppression and the Role of Suppressive Factors in Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of two distinct primary T cell populations that secrete interleukin 2 upon recognition of class I or class II major histocompatibility antigens

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T-T cell interactions during cytotoxic T lymphocyte (CTL) responses: T cell derived helper factor (Interleukin 2) as a probe to analyze CTL responsiveness and thymic maturation of CTL progenitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modes of cell:cell communication in the immune system

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The augmentation of tumor-specific immunity by virus help. II. Enhanced induction of cytotoxic T lymphocyte and antibody responses to tumor antigens by vaccinia virus-reactive helper T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunogenicity of "nonimmunogenic" tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The augmentation of tumor-specific immunity using haptenic muramyl dipeptide (MDP) derivatives. I. Synthesis of a novel haptenic MDP derivative cross-reactive with Bacillus Calmette Guerin and its application to enhanced induction of tumor immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regualtion of the immune response to tumor antigens. I. Immunosuppressor cells in tumor-bearing hosts

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Studies on the recovery from tolerance to tumor antigens. II. Accelerated recovery of tumor-specific effector T cells in tolerant mice by applying T-T cell interaction mechanism

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The augmentation of tumor-specific immunity by virus help. III. Enhanced generation of tumor-specific Lyt-1+2- T cells is responsible for augmented tumor immunity in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/2974763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00051371

1 reference

Europe PubMed Central

12 September 2017

1 reference

Europe PubMed Central

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39488901&oldid=1830882032"